Stronger Sell Today XBIO ranks #4862 as SELL CANDIDATE #4862 Weaker Sell

XBIO stock forecast Xenetic Biosciences Inc

XBIO stock forecast





XBIO Forecast and Technical Stock Analysis

Sell candidate since 2019-07-18

Xenetic Biosciences Inc fell by -9.27% in the last day ( Thursday, 18th Jul 2019 ) from $5.50 to $4.99 and has now fallen 3 days in a row. During day the stock fluctuated 18.45% from a day low at $4.60 to a day high of $5.45. The price has been going up and down for this period, and there has been a -43.3% loss for the last 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -560 067 shares and in total 252 722 shares bought and sold for approximately $1.26 million.

Quick summary:

  • 30 day high of the XBIO stock price was $16.89 and low was $0.51.
  • 90 day high was $16.89 and low was $0.51.
  • 52 week high for the Xenetic Biosciences Inc - $16.89 and low - $0.51.
Top Trending Stocks


Xenetic Biosciences Inc lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $3.41 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 271.61% during the next 3 months and, with 90% probability hold a price between $12.66 and $49.55 at the end of this period.

Top Golden Star Stocks


There are few to none technical positive signals at the moment. Xenetic Biosciences Inc holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $9.62 and $5.09. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday July 12, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 80 ]

RSI14 is 43 and the stock is currently not being overbought or oversold

* uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Support & Resistance

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

Price: $4.99 Resistance: $5.50


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.85 between high and low, or 18.45%. For the last week the stock has had a daily average volatility of 17.63%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

17.63 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Sell Candidate Downgraded


The Xenetic Biosciences Inc stock holds several negative signals and despite the positive trend we believe Xenetic Biosciences Inc will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.

Stronger Sell Today XBIO ranks #4862 as SELL CANDIDATE #4862 Weaker Sell

Will XBIO stock price go up or down on Mon, 22 Jul 2019?

Trading With Moving Average
As an investor, you always seek to understand what other... Full Article
Pivot Points
Pivot Points refer to points of significant change. As a... Full Article
Accumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full Article
Volume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full Article
We Give Back!
In 2016 donated to NGO Goodwill projects to help purchase medical... Full Article
Better Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full Article

Proudly made at